- HK$5.87bn
- HK$8.52bn
- CNY2.65bn
China's Jinxin Fertility Group interim revenue rises on U.S. IVF demand
Brief: Jinxin Fertility Group Expects Turnaround To Net Profit Of At Least Rmb90 Million For 1H2026
Brief: Jinxin Fertility Group Considers Launch Of Asset-Backed Securities Program
Brief: Jinxin Fertility Posts FY Revenue RMB 2,649.1 Million
Brief: Jinxin Fertility To Repurchase Shares At Aggregate Of Not Less Than Hk$100 Million
Brief: Jinxin Fertility Says John G. Wilcox Resigned As Executive Director
Brief: Jinxin Fertility Logs H1 Adjusted Net Income RMB82.3 Mln
Brief: Jinxin Fertility Expects Loss Of Not More Than RMB1,090 Million For HY
Brief: Jinxin Fertility Says Zhong Yong Redesignated From An Executive Director To A Non-Executive Director
Brief: Jinxin Fertility Group Posts H1 Net Income RMB190.3 Million
Brief: Jinxin Fertility Group Noted Recent Unusual Movements In Shares Of Co
Brief: Jinxin Fertility Group Says Final Dividend Of Hk$5.95 Cents Per Share
Brief: Jinxin Fertility Group Sees Net Profit & Adjusted Net Profit (Non-IFRS Measure) To Increase By No Less Than 192% & 71% For FY
Brief: Jinxin Fertility Group Says Huang Hanmei Appointed As CFO
Brief: Jinxin Fertility Group Posts HY Revenue Of RMB1,333.9 Mln
Brief: Jinxin Fertility Group Posts FY Profit Attributable Of RMB121.1 Mln
China's Jinxin Fertility falls on discounted share sale; Morimatsu drops
Co To Place 175 Million Shares At A Price Of Hk$6.725/Share
Brief: Jinxin Fertility Says Unit Has Agreed To Transfer 100% Stake In Jinxin Medical Investment